Related Experiment Videos
[Ab interno trabeculectomy with the Nd:YLF picosecond laser]
K Rohrschneider1, F E Kruse, R Kessler
1Universitäts-Augenklinik, Ruprecht-Karls-Universität Heidelberg. Klaus_Rohrschneider@med.uni-heidelberg.de
Summary
A novel Nd:YLF picosecond laser can ablate trabecular meshwork tissue ab interno, offering a potential alternative to traditional glaucoma surgery by avoiding eye opening and limiting scar formation.
Area of Science:
- Ophthalmology
- Laser Physics
- Biomedical Engineering
Context:
- Glaucoma surgery outcomes are often compromised by scar tissue formation.
- Current surgical techniques for glaucoma carry risks associated with opening the eye.
- Increasing aqueous humor outflow is a key goal in glaucoma management.
Purpose:
- To investigate the efficacy of a Neodymium-doped Yttrium Lithium Fluoride (Nd:YLF) picosecond laser for ab interno ablation of the trabecular meshwork.
- To determine if laser ablation can be performed without surgically opening the eye.
- To assess the potential of this technique as an alternative to conventional glaucoma surgeries.
Summary:
- A Nd:YLF picosecond laser, capable of tissue ablation through fluids, was utilized in postmortem eyes.
- Different spot sizes and energy levels were tested, with successful trabecular meshwork ablation achieved at 10 J/cm².
- Electron microscopy confirmed the effects of laser treatment, with a focus size of approximately 50 microns.
Impact:
- This study demonstrates the feasibility of using a picosecond laser for minimally invasive trabecular meshwork ablation.
- The findings suggest a promising new approach for glaucoma treatment, potentially reducing surgical complications.
- Further research could lead to improved surgical options for patients with glaucoma, enhancing aqueous humor outflow.